These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 19839847)
21. Angiopoietin as a Novel Prognostic Marker in Kidney Disease. Yildiz AB; Copur S; Tanriover C; Yavuz F; Vehbi S; Gaipov A; Magagnoli L; Ciceri P; Cozzolino M; Kanbay M Blood Purif; 2024; 53(6):425-435. PubMed ID: 38262381 [TBL] [Abstract][Full Text] [Related]
22. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Lee KW; Lip GY; Blann AD Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795 [TBL] [Abstract][Full Text] [Related]
23. Altered renal function in normoalbuminuric type 2 diabetes. Futrakul N; Vongthavarawat V; Chairatanarat T; Sirisalipotch S; Futrakul P; Suwanwalaikorn S Ren Fail; 2004 Nov; 26(6):727-8. PubMed ID: 15600266 [TBL] [Abstract][Full Text] [Related]
24. High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. Gambaro G; Bonfante L; Abaterusso C; Gemelli A; Ferraro PM; Marchesini S; De Conti G; D'Angelo A; Lupo A Nephrol Dial Transplant; 2012 Feb; 27(2):746-51. PubMed ID: 21737518 [TBL] [Abstract][Full Text] [Related]
25. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157 [TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia. Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510 [TBL] [Abstract][Full Text] [Related]
27. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity. Anagnostopoulos A; Eleftherakis-Papaiakovou V; Kastritis E; Tsionos K; Bamias A; Meletis J; Dimopoulos MA; Terpos E Br J Haematol; 2007 Jun; 137(6):560-8. PubMed ID: 17451406 [TBL] [Abstract][Full Text] [Related]
28. Adiponectin is related to markers of endothelial dysfunction and neoangiogenesis in diabetic patients. Kacso T; Bondor CI; Rusu CC; Moldovan D; Trinescu D; Coman LA; Ticala M; Gavrilas AM; Potra AR Int Urol Nephrol; 2018 Sep; 50(9):1661-1666. PubMed ID: 29804241 [TBL] [Abstract][Full Text] [Related]
29. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. David S; Kümpers P; Lukasz A; Fliser D; Martens-Lobenhoffer J; Bode-Böger SM; Kliem V; Haller H; Kielstein JT Nephrol Dial Transplant; 2010 Aug; 25(8):2571-6. PubMed ID: 20179005 [TBL] [Abstract][Full Text] [Related]
30. Serum angiopoietin-1 as a prognostic marker in resected early stage lung cancer. Park JH; Choi H; Kim YB; Kim YS; Sheen SS; Choi JH; Lee HL; Lee KS; Chung WY; Lee S; Park KJ; Hwang SC; Lee KB; Park KJ Lung Cancer; 2009 Dec; 66(3):359-64. PubMed ID: 19339077 [TBL] [Abstract][Full Text] [Related]
31. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Zeng W; Gouw AS; van den Heuvel MC; Zwiers PJ; Zondervan PE; Poppema S; Zhang N; Platteel I; de Jong KP; Molema G Hepatology; 2008 Nov; 48(5):1517-27. PubMed ID: 18924243 [TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli. Shimizu M; Inoue N; Kuroda M; Mizuta M; Sugimoto N; Kaneda H; Ohta K; Yachie A Clin Exp Nephrol; 2017 Feb; 21(1):76-82. PubMed ID: 26945868 [TBL] [Abstract][Full Text] [Related]
33. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286 [TBL] [Abstract][Full Text] [Related]
34. Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Jie KE; Zaikova MA; Bergevoet MW; Westerweel PE; Rastmanesh M; Blankestijn PJ; Boer WH; Braam B; Verhaar MC Nephrol Dial Transplant; 2010 Jun; 25(6):1875-82. PubMed ID: 20083473 [TBL] [Abstract][Full Text] [Related]
35. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure. Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667 [TBL] [Abstract][Full Text] [Related]
36. Angiopoietin-2, Angiopoietin-1 and subclinical cardiovascular disease in Chronic Kidney Disease. Tsai YC; Lee CS; Chiu YW; Kuo HT; Lee SC; Hwang SJ; Kuo MC; Chen HC Sci Rep; 2016 Dec; 6():39400. PubMed ID: 27991547 [TBL] [Abstract][Full Text] [Related]